Physician profile
Anne-Marie Singleton
NPI 1235199647
$1,201.97
in general payments reported to CMS, 2019-2025
15 companies · $453 in 2025
The $453 reported for 2025 was more than what 80% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $110 · 2022: $102 · 2023: $298 · 2024: $239 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.96 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $350.62 | 2021-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $285.12 | 2024-2025 | Slynd, Twirla |
| Hologic Sales and Service, LLC | $143.59 | 2021-2025 | Aptima |
| Abbvie INC. | $100.67 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $69.53 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $55.15 | 2022-2025 | |
| Millicent US INC | $41.25 | 2024-2025 | Intrarosa, Femring |
| Ethicon US, LLC | $32.61 | 2022 | |
| Teleflex LLC | $24.76 | 2025 | Quikclot |
| Amgen INC. | $19.12 | 2024 | Evenity, Prolia |
| Pfizer INC. | $18.94 | 2024 | |
| Acella Pharmaceuticals, LLC | $16.92 | 2022 | |
| Merck Sharp & Dohme LLC | $15.40 | 2023 | Gardasil 9 |
| Lilly USA, LLC | $14.75 | 2024 | Zepbound |
| Mayne Pharma Commercial LLC | $13.54 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne-Marie Singleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.